Nishan M DeSilva Insider Trading $LGND LIGAND PHARMACEUTICALS INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Nishan M DeSilva.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Nishan M DeSilva. Nishan M DeSilva is VP, Corporate Development in LIGAND PHARMACEUTICALS INC ($LGND).
Nishan M DeSilva in LIGAND PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Nishan M DeSilva: VP, Corporate Development
Holdings: 22,282 shares
Current Value: $2,402,891
Latest Transaction: Feb 11 2015
$LGND Market Capitalization: $2.24B
$LGND Previous Close: $107.84
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Nishan M DeSilva in LIGAND PHARMACEUTICALS INC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 11 2015 | LGND | LIGAND PHARMACEUTI ... | DeSilva Nishan M | VP, Corporate Devel ... | Option Exercise | A | 56.26 | 20,873 | 1,174,315 | 20,873 | |
| Feb 11 2015 | LGND | LIGAND PHARMACEUTI ... | DeSilva Nishan M | VP, Corporate Devel ... | Grant | A | 0.00 | 5,923 | 0 | 22,282 | 16.4 K to 22.3 K (+36.21 %) |
| Feb 11 2015 | LGND | LIGAND PHARMACEUTI ... | DeSilva Nishan M | VP, Corporate Devel ... | Sell | S | 56.34 | 2,300 | 129,582 | 16,359 | 18.7 K to 16.4 K (-12.33 %) |
| Feb 14 2014 | LGND | LIGAND PHARMACEUTI ... | DeSilva Nishan M | VP, Corporate Devel ... | Option Exercise | A | 74.42 | 5,000 | 372,100 | 45,000 | |
| Feb 14 2014 | LGND | LIGAND PHARMACEUTI ... | DeSilva Nishan M | VP, Corporate Devel ... | Option Exercise | A | 74.42 | 5,000 | 372,100 | 40,000 | |
| Feb 14 2014 | LGND | LIGAND PHARMACEUTI ... | DeSilva Nishan M | VP, Corporate Devel ... | Option Exercise | A | 74.42 | 35,000 | 2,604,700 | 35,000 | |
| Feb 14 2014 | LGND | LIGAND PHARMACEUTI ... | DeSilva Nishan M | VP, Corporate Devel ... | Grant | A | 0.00 | 3,000 | 0 | 18,659 | 15.7 K to 18.7 K (+19.16 %) |
| Jul 01 2013 | LGND | LIGAND PHARMACEUTI ... | DeSilva Nishan M | VP, Corporate Devel ... | Buy | P | 17.36 | 169 | 2,934 | 15,659 | 15.5 K to 15.7 K (+1.09 %) |
| Feb 19 2013 | LGND | LIGAND PHARMACEUTI ... | DeSilva Nishan M | VP, Corporate Devel ... | Option Exercise | A | 21.92 | 40,626 | 890,522 | 40,626 | |
| Feb 19 2013 | LGND | LIGAND PHARMACEUTI ... | DeSilva Nishan M | VP, Corporate Devel ... | Option Exercise | A | 21.92 | 4,374 | 95,878 | 4,374 | |
| Feb 19 2013 | LGND | LIGAND PHARMACEUTI ... | DeSilva Nishan M | VP, Corporate Devel ... | Grant | A | 0.00 | 5,000 | 0 | 15,490 | 10.5 K to 15.5 K (+47.66 %) |
| Jan 03 2013 | LGND | LIGAND PHARMACEUTI ... | DeSilva Nishan M | VP, Corporate Devel ... | Buy | J | 14.54 | 490 | 7,122 | 10,490 | 10 K to 10.5 K (+4.90 %) |
Page: 1